ProfileGDS5822 / ILMN_2973020
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 88% 90% 87% 86% 91% 88% 89% 87% 91% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1368.788
GSM1276600PDAC Late Ablation Control 2530.890
GSM1276601PDAC Late Ablation Control 3400.587
GSM1276602PDAC Late Ablation 1281.986
GSM1276603PDAC Late Ablation 2562.691
GSM1276604PDAC Late Ablation 3422.388
GSM1303940PDAC Late Ablation_anti-CTLA4 1418.489
GSM1303941PDAC Late Ablation_anti-CTLA4 2388.487
GSM1303942PDAC Late Ablation_anti-CTLA4 3687.591